Rheumatology
Lupus: On Treatment, Still Waiting for Relief.
KEEP heard from 31 people with confirmed lupus between September and October 2026. Treatment is common but relief is not: 77% use a prescription treatment, yet 75% of them describe partial, poor, or no control, and 96% experience disruption daily or several times a week. Effectiveness leads their challenges, and 87% are very interested in other therapies or research. The report shows how to build support around the relief patients still need.
Patient RecruitmentPatient IntelligencePatient Experience
Key Highlights
75% on treatment report incomplete control
96% disrupted daily or several times a week
87% very interested in other therapies or research
Overview
31 confirmed lupus patients are on treatment but still disrupted most weeks, with effectiveness the top concern and strong interest in other options.
